Post by BioDuro

📢Our May newsletter is live. The modality landscape keeps expanding, and so does our work. This month's issue covers case studies on 𝗻𝗼𝗻-𝗼𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗮𝗻𝘁𝗶𝗯𝗼𝗱𝘆-𝗽𝗲𝗽𝘁𝗶𝗱𝗲 𝗰𝗼𝗻𝗷𝘂𝗴𝗮𝘁𝗲𝘀 (𝗔𝗣𝗖), 𝗦𝗧𝗔𝗧𝟲 𝗱𝗲𝗴𝗿𝗮𝗱𝗲𝗿 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝗹𝗼𝗴𝘆, and 𝗮 𝗖𝗡𝗦 𝗽𝗿𝗼𝗴𝗿𝗮𝗺 𝘁𝗵𝗮𝘁 𝘄𝗲𝗻𝘁 𝗳𝗿𝗼𝗺 𝗵𝗶𝘁 𝘁𝗼 𝗜𝗡𝗗 𝗶𝗻 1𝟴 𝗺𝗼𝗻𝘁𝗵𝘀 with process development integrated from day one. Plus, two on-demand webinars: one on accelerating ADC discovery through an integrated chemistry, biology, and DMPK workflow with a 𝗽𝗵𝗼𝘁𝗼-𝗔𝗗𝗖 case study, and one on 𝗰𝘆𝗰𝗹𝗶𝗰 𝗽𝗲𝗽𝘁𝗶𝗱𝗲 drug design bridging 𝗔𝗜-𝗱𝗿𝗶𝘃𝗲𝗻 𝗰𝗼𝗺𝗽𝘂𝘁𝗮𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗲𝘅𝗽𝗲𝗿𝗶𝗺𝗲𝗻𝘁𝗮𝗹 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆.    👉Read the full issue below.   #XDC #Peptide #PROTAC #ADC #DrugDiscovery